Sergei Gryaznov

Sergei Gryaznov

Chief Tech/Sci/R&D Officer at MAIA BIOTECHNOLOGY, INC.

Net worth: 54 883 $ as of 2026-09-29

66 year
Health Technology
Consumer Services

Profile

Sergei M.
Gryaznov
is the founder of Lynx Therapeutics, Inc. (1993).
Current job includes Chief Scientific Officer at MAIA Biotechnology, Inc. (2019 - present).
Former jobs include Chemistry Director at Geron Corp.
(2013) and Chief Technology Officer at Exicure Operating Co. Education includes graduate and doctorate degrees from Moscow State University Lomonosov.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-31 46,511 ( 0.08% ) 54 883 $ 2026-09-29

Sergei Gryaznov active positions

CompaniesPositionStart
MAIA BIOTECHNOLOGY, INC. Chief Tech/Sci/R&D Officer 2019-11-30

Former positions of Sergei Gryaznov

CompaniesPositionEnd
GERON CORPORATION Corporate Officer/Principal 2012-12-31
Corporate Officer/Principal 1996-12-31
Chief Tech/Sci/R&D Officer -
See the detail of Sergei Gryaznov's experience

Education of Sergei Gryaznov

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

56

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Sergei Gryaznov